Page 325 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 325

References     3


                   63. Ibrahim EH, Mehringer L, Prentice D, et al. Early versus late     80. Suchner U, Heyland DK, Peter K. Immune-modulatory actions of
                      enteral feeding of mechanically ventilated patients: results of a   arginine in the critically ill. Br J Nutr. 2002;87(suppl 1):S121-S132.
                      clinical trial. JPEN J Parenter Enteral Nutr. 2002;26:174-181.    81. Ochoa JB, Bernard AC, O’Brien WE, et al. Arginase I expression
                   64. Mentec H, Dupont H, Bocchetti M, Cani P, Ponche F, Bleichner G.    and activity in human mononuclear cells after injury. Ann Surg.
                      Upper digestive intolerance during enteral nutrition in critically   2001;233(3):393-399.
                      ill patients: frequency, risk factors, and complications. Crit Care     82. Luiking YC, Poeze M, Ramsay G, Deutz NE. Reduced citrulline
                      Med. 2001;29(10):1955-1961.                            production in sepsis is related to diminished de novo arginine
                   65. Artinian V, Krayem H, DiGiovine B. Effects of early enteral   and nitric oxide production. Am J Clin Nutr. January 2009;89(1):
                      feeding on the outcome of critically ill mechanically ventilated   142-152.
                      medical patients. Chest. April 2006;129(4):960-967.    83. Kao CC, Bandi V, Guntupalli KK, Wu M, Castillo L, Jahoor F.
                   66. Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and   Arginine, citrulline and nitric oxide metabolism in sepsis. Clin
                      outcomes of critically ill patients treated with vasopressors and   Sci (Lond). June 2, 2009;117(1):23-30.
                      mechanical ventilation. Am J Crit Care. May 2010;19(3):261-268.    84. Visser M, Vermeulen M, Richir M, van Leeuwen P, Oudemans-
                   67. Lukan JK, McClave SA, Stefater AJ, et al. Poor validity of   van Straaten H. Arginine/ADMA as a predictor of cardiac
                      residual volumes as a marker for risk of aspiration. Amer J Clin   output in septic shock patients. ESPEN, 2009. Clin Nutr. 2009;
                      Nutrit. 2002;75(2S):417-418S.                          4(suppl 2):8.
                   68. McClave SA, Demeo MT, Delegge MH, et al. North American     85. Critical Care Nutrition. Section 4.2: Composition of EN:
                      Summit on Aspiration in the Critically Ill Patient: consensus   Arginine  Containing Diets  http://www.criticalcarenutrition.
                      statement. JPEN J Parenter Enteral Nutr. 2002;26(6):S80-S85.  com/index.php?option=com_content&view=article&id=18&It
                   69. Heyland DK, Drover JW, MacDonald S, Novak F, Lam M. Effect   emid=10. Accessed March 25, 2011.
                      of postpyloric feeding on gastroesophageal regurgitation and     86. Heyland DK, Novak F. Immunonutrition in the critically ill
                      pulmonary microaspiration: results of a randomized controlled   patient: more harm than good? JPEN J Parenter Enteral Nutr.
                      trial. Crit Care Med. 2001;29(8):1495-1501.            2001;25:S51-S55.
                   70. Critical Care Nutrition. Clinical Practice Guidelines.  http://    87. Bertolini G, Iapichino G, Radrizzani D, et al. Early enteral
                      www.criticalcarenutrition.com/index.php?option=com_conte  immunonutrition in severely septic patients: results of an
                      nt&view=article&id=18&Itemid=10. Accessed March 23, 2011.  interim analysis of a randomized multicenter trial.  Int Care
                   71. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S,   Med. 2003;29:834-840.
                      Ferrer M. Supine body position as a risk factor for nosocomial     88. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral admin-
                      pneumonia in mechanically ventilated patients: a randomised   istration of a formula (Impact) supplemented with arginine,
                      trial. Lancet. 1999;354(9193):1851-1858.               nucleotides, and fish oil in intensive care unit patients: results of
                   72. van Nieuwenhoven CA, Vandenbroucke-Grauls C, van Tiel   a multicenter, prospective, randomized, clinical trial. Crit Care
                      FH, et al. Feasibility and effects of the semirecumbent posi-  Med. March 1995;23(3):436-449.
                      tion to prevent ventilator-associated pneumonia: a randomized     89. Dent, DL, Heyland DK, Levy H, et al. Immunonutrition may
                      study.Crit Care Med. 2006;34(2):396-402.               increase  mortality in  critically  ill  patients  with  Pneumonia:
                   73. Booth CM, Heyland DK, Paterson WG. Gastrointestinal pro-  Results of a randomized trial. Crit Care Med. 2003;30:A17.
                      motility drugs in the critical care setting: a systematic review of     90. Galban C, Montejo JC, Mesejo A, et al. An immune-enhancing
                      the evidence. Crit Care Med. July 2002;30(7):1429-1435.  enteral diet reduces mortality rate and episodes of bacteremia
                   74. Nguyen NQ, Chapman M, Fraser RJ, Bryant LK, Burgstad C,    in septic intensive care unit patients.  Crit Care Med. March
                      Holloway RH. Prokinetic therapy for feed intolerance in crit-  2000;28(3):643-648.
                      ical illness: one drug or two?  Crit Care Med. November     91. Schloerb PR. Immune-enhancing diets: products, compo-
                      2007;35(11):2561-2567.                                 nents, and their rationales. JPEN J Parenter Enteral Nutr. 2001;
                   75. Heyland DK, Konopad E, Alberda C, Keefe L, Cooper C,   25(2 suppl):S3-S7.
                      Cantwell B. How well do critically ill patients tolerate early,     92. Fan Y, Chapkin RS. Importance of dietary  γ-linoleic acid in
                      intragastric enteral feeding? Results of a prospective multicenter   human health and nutrition. J Nutrit. 1998;128:1411-1414.
                      trial. Nutr Clin Pract. 1999;14:23-28.               93. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral
                   76. Spain DA, McClave SA, Sexton LK, et al. Infusion protocol   feeding with eicosapentaenoic acid, gamma-linolenic acid, and
                      improves delivery of enteral tube feeding in the critical care   antioxidants in patients with acute respiratory distress syn-
                      unit. JPEN J Parenter Enteral Nutr. 1999;23:288-292.   drome. Crit Care Med. 1999;27:1409-1420.
                   77. Heyland DK, Cahill NE, Dhaliwal R, Sun X, Day AG,      94. Pontes-Arruda A, Aragao AM, Albuquerque JD. Effects of enteral
                      McClave SA. Impact of enteral feeding protocols on enteral nutri-  feeding with eicosapentaenoic acid, gamma-linolenic acid, and
                      tion delivery: results of a multicenter observational study. JPEN J   antioxidants in mechanically ventilated patients with severe sepsis
                      Parenter Enteral Nutr. November-December 2010;34(6):675-684.  and septic shock. Crit Care Med. September 2006;34(9):2325-2333.
                   78. Montejo JC, Miñambres E, Bordejé L, et al. Gastric residual     95. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen
                      volume during enteral nutrition in ICU patients: the REGANE   J. Benefit of an enteral diet enriched with eicosapentaenoic acid
                      study. Intensive Care Med. August 2010;36(8):1386-1393.  and gamma-linolenic acid in ventilated patients with acute lung
                   79. McClave SA, Lukan JK, Stefater JA, et al. Poor validity of   injury. Crit Care Med. April 2006;34(4):1033-1038.
                      residual volumes as a marker for risk of aspiration in critically     96. Grau-Carmona T, Moran-Garcia V, de Lorenzo AC, et al. Effect
                      ill patients. Crit Care Med. February 2005;33(2):324-330.  of an enteral feeding with eicosapentaenoic and gamma-linoleic









          Section02-O-ref.indd   3                                                                                  12/10/2014   8:59:21 PM
   320   321   322   323   324   325   326   327   328   329   330